BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartono SB, Hadisoewignyo L, Yang Y, Meka AK, Antaresti, Yu C. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Nanotechnology 2016;27:505605. [DOI: 10.1088/0957-4484/27/50/505605] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Florek J, Caillard R, Kleitz F. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. Nanoscale. 2017;9:15252-15277. [PMID: 28984885 DOI: 10.1039/c7nr05762h] [Cited by in Crossref: 108] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
2 Peyvand P, Vaezi Z, Sedghi M, Dalir N, Ma’mani L, Naderi-manesh H. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery. Pharmaceutical Development and Technology 2020;25:1150-61. [DOI: 10.1080/10837450.2020.1803909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guo Y, Wu L, Gou K, Wang Y, Hu B, Pang Y, Li S, Li H. Functional mesoporous silica nanoparticles for delivering nimesulide with chiral recognition performance. Microporous and Mesoporous Materials 2020;294:109862. [DOI: 10.1016/j.micromeso.2019.109862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Pote AK, Pande VV, Patel VP, Giri MA, Pund AU, Shelke NV. State of the Art Review on Emerging Applications of Mesoporous Silica. TONMJ 2020;6:12-20. [DOI: 10.2174/2666150002006010012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mashayekhi S, Rasoulpoor S, Shabani S, Esmaeilizadeh N, Serati-nouri H, Sheervalilou R, Pilehvar-soltanahmadi Y. Curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for supporting long-term proliferation and stemness preservation of adipose-derived stem cells. International Journal of Pharmaceutics 2020;587:119656. [DOI: 10.1016/j.ijpharm.2020.119656] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
6 Liu Q, Han C, Tian Y, Liu T. Fabrication of curcumin-loaded zein nanoparticles stabilized by sodium caseinate/sodium alginate: Curcumin solubility, thermal properties, rheology, and stability. Process Biochemistry 2020;94:30-8. [DOI: 10.1016/j.procbio.2020.03.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
7 Ahali Abadeh Z, Saviano G, Ballirano P, Santonicola MG. Curcumin-loaded zeolite as anticancer drug carrier: effect of curcumin adsorption on zeolite structure. Pure and Applied Chemistry 2020;92:461-71. [DOI: 10.1515/pac-2018-1213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
8 Rathinavel S, Korrapati PS, Kalaiselvi P, Dharmalingam S. Mesoporous silica incorporated PCL/Curcumin nanofiber for wound healing application. Eur J Pharm Sci 2021;167:106021. [PMID: 34571179 DOI: 10.1016/j.ejps.2021.106021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mohebian Z, Babazadeh M, Zarghami N, Mousazadeh H. Anticancer efficiency of curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for potential postsurgical breast cancer treatment. Journal of Drug Delivery Science and Technology 2021;61:102170. [DOI: 10.1016/j.jddst.2020.102170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pereira de Sousa I, Gourmel C, Berkovska O, Burger M, Leroux J. A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study. Sci Rep 2020;10. [DOI: 10.1038/s41598-020-60463-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Sábio RM, Meneguin AB, Martins dos Santos A, Monteiro AS, Chorilli M. Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration. Microporous and Mesoporous Materials 2021;312:110774. [DOI: 10.1016/j.micromeso.2020.110774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
12 Juère E, Florek J, Bouchoucha M, Jambhrunkar S, Wong KY, Popat A, Kleitz F. In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles. Mol Pharm 2017;14:4431-41. [PMID: 29094948 DOI: 10.1021/acs.molpharmaceut.7b00529] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
13 Ghosh S, Ghosh S, Sil PC. Role of nanostructures in improvising oral medicine. Toxicol Rep 2019;6:358-68. [PMID: 31080743 DOI: 10.1016/j.toxrep.2019.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
14 Ban C, Jo M, Park YH, Kim JH, Han JY, Lee KW, Kweon D, Choi YJ. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Food Chemistry 2020;302:125328. [DOI: 10.1016/j.foodchem.2019.125328] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 24.5] [Reference Citation Analysis]
15 Li N, Niu D, Jiang Y, Xu C, Pan S, He J, Chen J, Zhang L, Li Y. Morphology Evolution and Spatially Selective Functionalization of Hierarchically Porous Silica Nanospheres for Improved Multidrug Delivery. Chem Mater 2017;29:10377-85. [DOI: 10.1021/acs.chemmater.7b03735] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
16 Shah P, Rajput SJ. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene. Drug Dev Ind Pharm 2019;45:587-602. [PMID: 30633575 DOI: 10.1080/03639045.2019.1569028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Zheng N, Li J, Xu C, Xu L, Li S, Xu L. Mesoporous silica nanorods for improved oral drug absorption. Artif Cells Nanomed Biotechnol 2018;46:1132-40. [PMID: 28783976 DOI: 10.1080/21691401.2017.1362414] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
18 Yoon HJ, Zhang X, Kang MG, Kim GJ, Shin SY, Baek SH, Lee BN, Hong SJ, Kim JT, Hong K, Bae H. Cytotoxicity Evaluation of Turmeric Extract Incorporated Oil-in-Water Nanoemulsion. Int J Mol Sci 2018;19:E280. [PMID: 29342111 DOI: 10.3390/ijms19010280] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
19 Kumar P, Tambe P, Paknikar KM, Gajbhiye V. Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform. J Control Release 2018;287:35-57. [PMID: 30125637 DOI: 10.1016/j.jconrel.2018.08.024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
20 Wibowo FR, Saputra OA, Lestari WW, Koketsu M, Mukti RR, Martien R. pH-Triggered Drug Release Controlled by Poly(Styrene Sulfonate) Growth Hollow Mesoporous Silica Nanoparticles. ACS Omega 2020;5:4261-9. [PMID: 32149256 DOI: 10.1021/acsomega.9b04167] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
21 Zhang J, Liu J, Ren L, Wei J, Zhang F, Li Y, Guo C, Duan J, Sun Z, Zhou X. Silica nanoparticles induce abnormal mitosis and apoptosis via PKC-δ mediated negative signaling pathway in GC-2 cells of mice. Chemosphere 2018;208:942-50. [DOI: 10.1016/j.chemosphere.2018.05.178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
22 Lather V, Poonia N, Pandita D. Mesoporous Silica Nanoparticles. In: Barkat MA, A.b. H, Beg S, Ahmad FJ, editors. Multifunctional Nanocarriers for Contemporary Healthcare Applications. IGI Global; 2018. pp. 192-246. [DOI: 10.4018/978-1-5225-4781-5.ch008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. Int J Nanomedicine 2021;16:1961-76. [PMID: 33727809 DOI: 10.2147/IJN.S278724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Xu L, Li W, Sadeghi-Soureh S, Amirsaadat S, Pourpirali R, Alijani S. Dual drug release mechanisms through mesoporous silica nanoparticle/electrospun nanofiber for enhanced anticancer efficiency of curcumin. J Biomed Mater Res A 2021. [PMID: 34378328 DOI: 10.1002/jbm.a.37288] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Ma Z, Wang N, He H, Tang X. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. Journal of Controlled Release 2019;316:359-80. [DOI: 10.1016/j.jconrel.2019.10.053] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 17.3] [Reference Citation Analysis]